These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3630357)

  • 1. [Study of the DNA-binding capacity of the blood serum in evaluating the activity of systemic lupus erythematosus and scleroderma].
    Glavinskaia TA; Rezaĭkina AV; Komarova VD
    Vestn Dermatol Venerol; 1987; (6):20-2. PubMed ID: 3630357
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antinuclear autoantibodies in systemic diseases].
    Butov IuS
    Vestn Dermatol Venerol; 1980 Nov; (11):17-22. PubMed ID: 7003977
    [No Abstract]   [Full Text] [Related]  

  • 3. Circumscribed scleroderma with immunologic evidence of systemic lupus erythematosus.
    Mitchell AJ; Rusin LJ; Diaz LA
    Arch Dermatol; 1980 Jan; 116(1):69-73. PubMed ID: 6153258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Humoral and cellular immunity indices in lupus erythematosus and scleroderma].
    Butov IuS; Skripkin IuK; Koshevenko IuN
    Vestn Dermatol Venerol; 1978 Apr; (4):7-11. PubMed ID: 77599
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complement binding anti-DNA antibodies: its clinical significance in systemic lupus erythematosus].
    Pigrau A; Martínez-Vázquez JM; Bacardí R; Ocanña I; Pahissa A
    Med Clin (Barc); 1984 Dec; 83(19):787-91. PubMed ID: 6335542
    [No Abstract]   [Full Text] [Related]  

  • 7. Idiotypic/antiidiotypic interactions in systemic lupus erythematosus: demonstration of oscillating levels of anti-DNA autoantibodies and reciprocal antiidiotypic activity in a single patient.
    Zouali M; Eyquem A
    Ann Immunol (Paris); 1983; 134C(3):377-91. PubMed ID: 6625532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of DNA-binding activity of blood serum in systemic lupus erythematosus, rheumatoid arthritis and crossing syndromes].
    Matveĭkov GP; Podgorodnichenko VK; Koshelev VK; Nazarov IuM
    Ter Arkh; 1976; 48(11):36-40. PubMed ID: 1021891
    [No Abstract]   [Full Text] [Related]  

  • 9. Hybridoma anti-DNA autoantibodies from patients with rheumatoid arthritis and systemic lupus erythematosus demonstrate similar nucleic acid binding characteristics.
    Rauch J; Massicotte H; Tannenbaum H
    J Immunol; 1985 Jan; 134(1):180-6. PubMed ID: 3964813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levamisole in the treatment of systemic lupus erythematosus--preliminary results.
    Feng PH; Oon CJ; Yo SL; Lau YK
    Singapore Med J; 1978 Sep; 19(3):120-4. PubMed ID: 751195
    [No Abstract]   [Full Text] [Related]  

  • 11. [HLA and ceruloplasmin phenotypes in lupus erythematosus and circumscribed scleroderma].
    Glavinskaia TA; Rezaĭkina AV; Komarova VD; Sidorova TI
    Vestn Dermatol Venerol; 1989; (6):9-13. PubMed ID: 2588797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent aspects of selected autoantibodies in patients with systemic lupus erythematosus and their clinical relevance. I. DNA-binding autoantibodies].
    Wollina U
    Allerg Immunol (Leipz); 1983; 29(3):127-34. PubMed ID: 6227213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of treatment with enkorton and cytostatics on selected immunologic indicators in patients with systemic lupus erythematosus].
    Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Jedryka-Góral A; Swierczyńska Z; Rdułtowska H; Luft S; Rogozińska E
    Reumatologia; 1982; 20(1-2):7-14. PubMed ID: 7163667
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibodies cross-reactive with DNA and cardiolipin in patients with systemic lupus erythematosus.
    Koike T; Tomioka H; Kumagai A
    Clin Exp Immunol; 1982 Nov; 50(2):298-302. PubMed ID: 7151328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of serum IgG, IgM, and anti-native-DNA antibodies with renal and clinical indexes of activity in systemic lupus erythematosus.
    Feldman MD; Huston DP; Karsh J; Balow JE; Klima E; Steinberg AD
    J Rheumatol; 1982; 9(1):52-8. PubMed ID: 7045362
    [No Abstract]   [Full Text] [Related]  

  • 17. High-avidity anti-DNA antibody removal from the serum of systemic lupus erythematosus patients by adsorption using dextran sulfate cellulose columns.
    Matsuki Y; Suzuki K; Kawakami M; Ishizuka T; Kawaguchi Y; Hidaka T; Nakamura H
    J Clin Apher; 1996; 11(1):30-5. PubMed ID: 8722720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinucleosome antibody is a major autoantibody in localized scleroderma.
    Sato S; Kodera M; Hasegawa M; Fujimoto M; Takehara K
    Br J Dermatol; 2004 Dec; 151(6):1182-8. PubMed ID: 15606513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in patients with oral lupus erythematosus, lichen planus and leukoplakia. An aid in diagnosis.
    Schiødt M; Permin H; Wiik A; Manthorpe R
    Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):59-63. PubMed ID: 6603096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of bemetil on the production of DNA antibodies in patients with systemic lupus erythematosus].
    Lisitsyna TA; Durnev AD; Ivanova MM; Speranskiĭ AI; Seredenin SB; Nasonova VA
    Eksp Klin Farmakol; 1999; 62(5):38-41. PubMed ID: 10572751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.